Additionally, erastin, a selective inhibitor of SLC7A11 (a cystine–glutamate antiporter also known as xCT) exhibited a synergistic effect in inducing ferroptosis in CRC cells when combined with oxaliplatin [156]. This evidence concerns the gene SLC7A11 and colorectal carcinoma.